Ma Luo, D Tang, J Pinto, M Nykoluk, P Lacap, J Tuff, E Shadabi, C Czarnecki, J Whitney, M Alonso, T Ball, G Kobinger, P Sandstrom and F Plummer
Qingsheng Li
Tat, the forgotten target that could help to cure from HIV
Erwann P Loret
Community engagement during the Ebola vaccine trial in Guinea
Godwin Enwere
Pre-clinical toxicology considerations in vaccine
Nabil Al-Humadi
Codon harmonization, a step beyond optimization to capture the natural rhythm of protein translation
Bettina Werle, N Mariano, C Mignon, S Chenavas, G Stadthagen, A Lugari, C Perot, S Donnat, P Lagoutte F Diot and R Sodoyer
Development of lipid based oral vaccine formulations
Sarah Margaret Hook
Viral vectored genetic vaccines: Current status and future perspectives
Antonella Folgori
Gunther Staffler
Anissa Boumlic-Courtade
Implementing a randomized control trial (RCT) in the context of an Ebola epidemic
Ana Maria Henao Restrepo
Peter Burkhard, Christopher Karch, Jianping Li, Caroline Kulangara, Sara M Paulillo, Senthil K Raman, Sharareh Emadi, Anmin Tan, Zeinab H Helal, Qing Fan, and Mazhar I Khan
Plant expression platforms for vaccine production
Kathleen Hefferon
Jacques Choucair and Sara Abboud
Ennima Imane, Sebbar Ghizlane, Harif Bachir, Amzazi Saaid, Loutfi Chafiqa and Touil Nadia
Bluetongue virus (BTV) serological survey and evidence of emergent BTV-8 serotype in Morocco
Kamar Drif
Khadija Khataby, Faouzi Kichou, Chafiqa Loutfi and My Mustapha Ennaji
Rapid development of an oral Zika virus vaccine
Sean N Tucker, Emery Dora and Christina Joyce
Timothy R Fouts
Measles: Need for continued vaccination and novel vaccines post virus eradication
S Louise Cosby
Evaluation of genetic stability of transgenes in vaccine
Ali Azizi
Viviane Maimoni Goncalves, Stefanie Kraschowetz, Douglas Borges de Figueiredo, Eneas Carvalho, Gilson Campani Jr, Gabriel Gonçalves, Eliane N Miyaji, Thiago R Converso, Luciana C C Leite, Teresa C Zangirolami and Joaquin Cabrera-Crespo
The key person influences flu vaccination among health workers: Perspective study of social network
Xiaoning Hao, Tao Bo and Jianchun Liu
Pneumococcal conjugate vaccine: Use of pneumococcal surface protein A (PspA) as carrier
Giovana Cappio Barazzone
Pneumococcal inactivated whole cell vaccine: Development of the production process
Viviane Maimoni Goncalves
Xiaoning Hao, Tao Bo and Zhi Liu
Randa Hamadeh, Walid Ammar and Gabriele Riedner
Fahad Saleh Al-Tayyeb
Jacques Choucair and Zaki Sleiman
Expanding the findings of RV144 to South Africa: P5 initiative
Glenda Gray
Barbara Ensoli
Current strategies for HIV remission: The role of therapeutic vaccines
Felipe Garcia Alcaide
Synthetic DNA vaccines for difficult mucosal viruses including HIV
Jean D Boyer
Potential development of inactivated HIV-1 transmitted/founder virus (T/F) vaccine
Adan Rios, Ethan C Pottet, Edward B Siwak, Dallas W Anderson and Qizhi C Yao
HIV vaccine development: Is a moral wrong occurring?
Mike King
Reverse HIV vaccinology failed because it has no sound theoretical basis in the case of this virus
Van Regenmortel Marc Hubert Victor
HIV replication is suppressed by CD8+T regulatory cells in elite controllers
Jean-Marie Andrieu
Eric Sandstrom
Massimo Amicosante
Massimo Amicosante
Vaccines for pregnant women - challenges and opportunities for harmonized safety monitoring
Sonali Kochhar
Timothy R Fouts
Ombretta Palucci
Ombretta Palucci
Post-marketing surveillance of BCG vaccination
Ruwen Jou
Novel vaccine adjuvants for animal infectious diseases
Jishu Shi
Ramesh Chintala
Immunogenicity of VLP forming baculoviral DNA vaccine
Young Bong Kim, Yong-Dae Gwon, Sehyun Kim, Yeondong Cho, Yoonki Heo, Hansam Cho, Kihoon Park, Hee-Jung Lee and Jiwon Choi
Targeting TLR9 and TLR21 to develop vaccine adjuvant for different species
Tsung-Hsien Chuang
Therapeutic vaccines for treatment of allergic and autoimmune diseases
Zhikang Peng
Therapeutic vaccines against chronic hepatitis-B virus and related complications
Sheikh Mohammad Fazle Akbar